{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
{{locationDetails}}
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
Asemblis is a Swiss TechBio company developing scalable, human-relevant in vitro models for obesity and metabolic disorders. The company partners with industry and research organizations to support translational R&D and decision-making in drug development
At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.
Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
CALDRE is a Switzerland based biotech spin-out focussed to revolutionize the way cholestatic-and fibrotic diseases are treated. We develop precise, liver-directed GalNAc-siRNAs to restore bile flow and prevent fibrosis - placing CALDRE in the fast-growing RNA-therapeutics segment of biotech.
We provide reliable rapid tests for the on-site detection of specific genes in a variety of microorganisms. Because of the increasing demand for quick and dependable results for the diagnosis of infectious diseases, we have developed a novel molecular detection method.
CSL (ASX:CSL; USOTC:CSLLY) – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – is a global biotechnology leader that develops and delivers innovative lifesaving medicines, protects public health and helps people with life-threatening medical conditions live full lives.
We are offering worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions. With over 20 years of experience in the field, we guarantee the best possible medical writing.
Preclinical Safety/Toxicology and Strategic Regulatory Consulting for biotech startups with focus from preclinic to first-in-human trial.
inSEIT solves the challenges of enzyme immobilization and unlocks the potential of immobilized biocatalysts for the production of APIs and chemical intermediates. We use bioinformatic tools to reduce the risk, time and cost associated with biocatalyst development.
PLX Healthcare Services, a Cencora PharmaLex company, is a solutions provider for the pharma, and biotech. We guide you from development stage to Registration and beyond. Our team of experts have also extensive experience with global supply chain regulations and successful market entry.
Risklick is shaping the future of clinical trial protocols by offering the first-of-its-kind, AI-based tool for developing high-quality clinical trial protocols and optimizing them efficiently, using historical data. We enable experts to develop high-quality protocols in a short time.
Headquartered in Switzerland with global operations, Space Peptides provides end-to-end pharmaceutical Peptide CRDMO services - covering discovery, process development, and GMP manufacturing. In addition, our portfolio comprises a broad range of generic Peptide APIs.
SAKK is a non-profit organization since 1965 investigating the efficacy and tolerability of new cancer therapies and further develops existing tumor treatments in adults. Our objective is to apply the best possible treatment. We see ourselves as the Swiss competency center for oncology trials.
Cannapharm AG produces cannabis based raw material for the production of pharmaceuticals and cannabis based extracts for pharmacies.
Euresearch is a non-profit organisation funded by the State Secretariat for Education, Research and Innovation SERI. We promote and facilitate the participation of researchers, organisations and companies in Switzerland in European projects and programmes related to research and innovation.
Innosuisse is the Swiss Agency for Innovation Promotion. We promote science-based innovation in the interest of business and society, thereby strengthening the competitiveness of small and medium-sized enterprises in Switzerland.
OnconiX AG transforms cancer care by replacing trial-and-error with test-before-treat precision. Using patient-derived tumor models and AI, we predict treatment response in days, enabling personalized therapy selection that improves outcomes and reduces unnecessary toxicity for patients with cancer.
ReseaChem was founded in 1996 as a spin-off company of the University of Applied Sciences Berne located in Burgdorf, Switzerland. ReseaChem offers a broad range of services in custom synthesis, analytics as well as isolation of chemical products.
Schaefer-Tec represents laboratory equipment for nanoparticle analysis (CytoViva) as well as 3D (live) cell imaging by Holo-Tomography (Tomocube). Gas-Flowmeter and Gas-Flowcontroller by Teledyne Hastings as well as Optical Microscopes by KERN.
Tools to foster industrial applicability and acceptance of in vitro. We aim to help unlock the value biologists have created in developing cell based assays, protocols and in-vitro expertise by advancing familiar labware technology.
STERIS Life Sciences is a global leader and partner in contamination control with a focus on sterilization, cleaning, and decontamination. Our innovative and comprehensive product portfolio along with technical expertise provides the resources you need to optimize your manufacturing processes.
Switzerland Innovation is a network of six innovation parks and 16 sites, with access to the expertise of world's leading universities, forming an ecosystem accelerating the transformation of research results into marketable products and services.
R&D oriented SME developing a portfolio of vaccines against infectious diseases. Dengue vaccine already on the market since 2024 and distributed via partenrs in Ais and Latin-America.